Tg Therapeutics (TGTX) Minority Interest (2011 - 2012)

Tg Therapeutics (TGTX) posted quarterly Minority Interest of $8.5 million for Q3 2012, down 2.83% quarter-over-quarter from $8.8 million in Q2 2012.

Tg Therapeutics (TGTX) Minority Interest (2011 - 2012) Analysis & Trends

Tg Therapeutics' Minority Interest history runs 2 years deep, the most recent figure standing at $8.5 million for Q3 2012.

In Q3 2012, Minority Interest changed N/A year-over-year to $8.5 million; the TTM figure through Sep 2012 stood at $8.5 million (changed N/A YoY), while the FY2012 annual figure was $9.4 million, changed N/A from the prior year.
Minority Interest for Q3 2012 stood at $8.5 million, down from $8.8 million in the prior quarter.
The five-year high for Minority Interest was $9.4 million in Q1 2012, with the low at $11681.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Tg Therapeutics	7.46 Bn	6.78 Bn	199.14 Mn

Download Data